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H ead and neck squamous cell carcinoma (HNSCC), a tumor group consisting of multiple histopathologies, is the fifth most common cancer in the United States, with an estimated 40 000 annual new cases 1 and a mortality rate of approximately 12 000 a year. 2 Despite advances in diagnosis and treatment options for HNSCC in the past 30 years, patient 5-year survival has only shown marginal improvement. 2 The major cause of death in patients with HNSCC is local invasion and regional and/or distant metastasis. Prognosis for patients with metastatic disease is poor, with a 5-year survival rate of only 17%. 3 Prognosis depends on factors such as clinical stage at the time of diagnosis, location of tumor, and proximity of blood and lymph vessels. [4] [5] [6] Thus, markers associated with biological aggressiveness are indicated to predict the outcome of the disease and in developing new treatment strategies.
Matrix metalloproteinases (MMPs), a family of zincdependent and calcium-dependent proteolytic enzymes, are able to degrade connective tissue, among other substrates, such as basement membrane collagen, and have been associated with cancer metastasis and tumor angiogenesis. Gelatinases, especially MMP-9 (gelatinase B) and MMP-2 (gelatinase A), play a key role in the degradation of collagen type IV and gelatin, 2 important components of the extracellular matrix (ECM). These gelatinases are expressed in head and neck carcinoma cells and are associated with progression and invasion of these tumors. [7] [8] [9] [10] For example, Ruokolainen et al 10 noted correlation of high MMP-9 expression in sections of head and neck carcinomas with aggressive relapses and shortened survival.
Rath and Pauling 11 postulated that nutrients such as lysine and ascorbic acid could act as natural inhibitors of ECM proteolysis and, as such, have the potential to modulate tumor growth and expansion. These nutrients can exercise their antitumor effect through the inhibition of MMPs and by strengthening connective tissue surrounding cancer cells by influencing collagen synthesis. These 2 processes are essential for a tumor encapsulating
Marked Inhibition of Growth and Invasive Parameters of Head and Neck Squamous Carcinoma
FaDu by a Nutrient Mixture effect. We have developed strategies to inhibit cancer development and its spread using naturally occurring nutrients such as lysine, proline, ascorbic acid, and green tea extract (NM). This nutrient mixture has exhibited synergistic anticancer activity in vivo and in vitro in a number of cancer cell lines, including human and murine melanoma cells lines, through inhibition of cancer cell growth, MMP secretion, invasion, metastasis, and angiogenesis. [12] [13] [14] The present study examines the effect of the NM on human HNSCC cell line FaDu, in vivo, in athymic nude mice bearing HNSCC FaDu xenografts, and in vitro, evaluating viability, MMP secretion, invasion, and induction of apoptosis.
The NM used in this study was designed by defining critical physiological targets in cancer progression and metastasis. These include ECM integrity and MMP activity. ECM formation and structure depend on adequate supplies of ascorbic acid and the amino acids lysine and proline, which ensure proper synthesis and hydroxylation of collagen fibers. Manganese and copper are also essential for collagen formation. Lysine is a natural inhibitor of plasmin-induced proteolysis and, as such, plays an important role in ECM stability. 11, 15 Green tea extract has shown to be a promising agent in controlling cancer cell growth, metastasis, angiogenesis, and other aspects of cancer progression. [16] [17] [18] [19] [20] N-acetylcysteine has been observed to inhibit MMP-9 activity 21 and invasive activities of tumor cells. 22 Selenium has been shown to interfere with MMP secretion and tumor invasion, 23 as well as migration of endothelial cells through the ECM. 22 In addition to addressing ECM properties, some nutrients are critical in inducing cancer cell death. A recent study confirmed that ascorbic acid inhibits cell division and growth through the production of hydrogen peroxide. 24 Because arginine is a precursor of nitric oxide, any deficiency of arginine can limit the production of nitric oxide, which has been shown to predominantly act as an inducer of apoptosis, as in breast cancer cells.
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Methods and Materials
Cancer Cell Line and Culture
Human FaDu cells obtained from the American Type Culture Collection (ATCC, Rockville, MD) were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/ mL streptomycin. The media and sera used were obtained from ATCC, and the antibiotics (penicillin and streptomycin) were from Gibco BRL (Long Island, NY).
Composition of the Nutrient Mixture
The NM used in this study was composed of the following in the ratio indicated: vitamin C (as ascorbic acid and as Mg, Ca, and palmitate ascorbate) 700 mg, L-lysine 1000 mg, L-proline 750 mg, L-arginine 500 mg, N-acetylcysteine 200 mg, standardized green tea extract (derived from green tea leaves; obtained from US Pharma Lab (North Brunswick, NJ); the certificate of analysis indicated the following characteristics: total polyphenol 80%, catechins 60%, epigallocatechin gallate 35%, and caffeine 1.0%) 1000 mg, selenium 30 µg, copper 2 mg, and manganese 1 mg.
In Vivo Studies
Animals. Male athymic mice (NCr-nu/nu), approximately 5 weeks of age on arrival, were purchased from Simonsen Laboratories (Gilroy, CA) and maintained in microisolator cages under pathogen-free conditions on a 12-hour light/ 12-hour dark schedule for a week. All procedures were performed according to humane and customary care and use of experimental animals and followed a protocol approved by an internal institutional animal safety review committee.
Experimental design. After housing for a week, the mice (n = 12) were inoculated subcutaneously with 3 × 10 6 FaDu cells (ATCC) in 0.2 mL phosphate-buffered saline (PBS) and 0.1 mL Matrigel (BD Bioscience, Bedford, MA). After injection, the mice were randomly divided into 2 groups: group A mice were fed regular Purina mouse chow and group B the regular diet supplemented with 0.5% NM (w/w). During the study, the mice consumed, on the average, 4 g of their respective diets per day. Thus, the supplemented mice received approximately 20 mg of NM per day. After 4 weeks, the mice were sacrificed and their tumors were excised and processed for histology. Mean weight of mice at initiation of study and termination of study did not differ significantly between the groups.
Histology. Tissue samples were fixed in 10% buffered formalin. All tissues were embedded in paraffin and cut at 4 to 5 µm. Sections were deparaffinized through xylene and graduated alcohol series to water and stained with hematoxylin and eosin (H&E) for evaluation using a standard light microscope.
In Vitro Studies
Cell culture. Human HNSCCs were grown in Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum, penicillin (100 U/mL), and streptomycin (100 mg/mL) in 24-well tissue culture plates (Costar, Cambridge, MA). Cells were incubated with 1 mL of media at 37°C in a tissue culture incubator equilibrated with 95% air and 5% CO 2 . At near confluence, the cells were treated with the NM, dissolved in media, and tested at 0, 10, 50, 100, 500, and 1000 µg/mL in triplicate at each dose. Phorbol 12-myristate 13-acetate (PMA), 200 ng/mL, was added to cells to induce MMP-9 secretion. The plates were then returned to the incubator.
MTT assay. Cell viability was evaluated by MTT assay, a colorimetric assay based on the ability of viable cells to reduce a soluble yellow tetrazolium salt-3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)-to a blue formazan crystal by mitochondrial succinate dehydrogenase activity of viable cells. This test is a good index of mitochondrial activity and thus of cell viability. After 24-hour incubation, the cells were washed with PBS, and 500 µL of MTT (Sigma #M-2128), 0.5 mg/mL in media, was added to each well. After MTT addition (0.5 mg/mL), the plates were covered and returned to the incubator at 37°C for 2 hours, the optimal time for formazan product formation. Following incubation, the supernatant was carefully removed from the wells, the formazan product was dissolved in 1 mL dimethyl sulfoxide (DMSO), and absorbance was measured at 570 nm in Bio Spec 1601, Shimadzu spectrometer. The OD 570 of the DMSO solution in each well was considered to be proportional to the number of cells. The OD 570 of the control (treatment without supplement) was considered 100%.
Gelatinase zymography. Gelatinase zymography was performed in 10% NOVEX Precast SDS Polyacrylamide Gel (Invitrogen Corporation, Carlsbad, CA) in the presence of 0.1% gelatin under nonreducing conditions. Culture media (20 µL) were mixed with sample buffer and loaded for SDS-PAGE with tris glycine SDS buffer, as suggested by the manufacturer (Novex, Carlsbad, CA). Samples were not boiled before electrophoresis. Following electrophoresis the gels were washed twice in 2.5% Triton X-100 for 30 minutes at room temperature to remove SDS. The gels were then incubated at 37°C overnight in substrate buffer containing 50 mM Tris-HCl and 10 mM CaCl 2 at pH 8.0 and stained with 0.5% Coomassie Blue R250 in 50% methanol and 10% glacial acetic acid for 30 minutes and destained. On renaturation of the enzyme, the gelatinases digested the gelatin in the gel, producing clear bands against an intensely stained background. Protein standards were run concurrently, and approximate molecular weights were determined by plotting the relative mobilities of known proteins.
Gelatinase zymograms were obtained using CanoScan 9950F Canon scanner at 300 dpi. The intensity of the bands was evaluated using the pixel-based densitometer program Un-Scan-It, Version 5.1, 32-bit, by Silk Scientific Corporation (Orem, UT), at a resolution of 1 Scanner Unit (1/100 of an inch for an image that was scanned at 100 dpi). The pixel densitometer calculates the optical density of each pixel (values 0 to 255) using the darkly stained background of the gel as a pixel value of 0. A logarithmic optical density scale was used because the optical density of films and gels is logarithmically proportional to the concentration. The pixel densitometer sums the optical density of each pixel to give a band's density. In all graphs, band densities are reported as a percentage of the sum of all pixels in a given lane of a gel.
Matrigel invasion. Invasion studies were conducted using Matrigel (Becton Dickinson, Franklin Lakes, NJ) inserts in 24-well plates. Suspended in medium, FaDu cells were supplemented with nutrients, as specified in the design of the experiment, and seeded on the insert in the well. Thus, the medium on both the insert and in the well contained the same supplements. The plates with the inserts were then incubated in a culture incubator equilibrated with 95% air and 5% CO 2 for 24 hours. After incubation, the media from the wells were withdrawn. The cells on the upper surface of the inserts were gently scrubbed away with cotton swabs. The cells that had penetrated the Matrigel membrane and migrated onto the lower surface of the Matrigel were stained with H&E and visually counted under the microscope.
Morphology and apoptosis. Morphology of cells cultured for
24 hours in test concentrations of NM were evaluated by H&E staining and observed and photographed by microscopy. At near confluence, FaDu cells were challenged with NM dissolved in media at 0, 50, 100, 250, 500, and 1000 µg/mL and incubated for 24 hours. The cell culture was washed with PBS and treated with the caspase reagent as specified in the manufacturer's protocol (Molecular Probes Image-IT Live Green Poly Caspases Detection Kit 135104, Invitrogen Corporation). The cells were photographed under a fluorescence microscope and counted. Green-colored cells represent viable cells, whereas yellow orange represents early apoptosis and red late apoptosis.
Statistical Analysis
The results were expressed as means ± standard deviation for the groups. Data were analyzed by independent-sample t test. Pearson's correlation coefficients were determined for toxicity and invasion correlations to NM concentration using MedCalc Software (Markakerke, Belgium).
Results
In Vivo
Tumor growth. NM strongly inhibited the growth of FaDu xenografts in nude mice. Mean tumor weight was significantly inhibited (by 55%, P = .0002) with NM 0.5% dietary supplementation, as shown in Figure 1 .
Histology. Histologically, tumor specimens from both groups consisted of a large central necrotic region and a peripheral collar of viable tumor tissue consistent with a poorly differentiated carcinoma. Necrosis involved 60% to 70% of the control group specimen (Figure 2A and B) and 40% to 50% of the supplemented group specimen ( Figure  2C and D) .
In Vitro
Cytotoxicity. NM exhibited dose-response toxicity on HNSCC FaDu cells in vitro, with maximum toxicity of 53% (P = .0003) over the control at 1000 µg/mL, as shown in Figure 3 . There was significant negative correlation between NM concentration and cell viability, with coefficient r = −.8769 (P < .0001).
Gelatinase zymography. Zymography showed a faint band representing MMP-2 in normal FaDu cells with induction of a strong band representing PMA-induced MMP-9 secretion. NM inhibited secretion of both MMPs in a dosedependent manner, with virtual total inhibition at 1000 µg/ mL, as shown in Figure 4A and B. Densitometric analysis of normal FaDu cell secretion showed 19% inhibition of MMP-2 at 100 µg/mL and 99% at 500 and 1000 µg/mL NM, with a linear trend of R 2 = .7809 ( Figure 4C ).
For PMA-induced FaDu cells, relative activity of MMP-2 revealed 56% inhibition at 50 µg/mL, 88% at 100 µg/mL, and 100% at 500 and 1000 µg/mL, with a linear trend of R 2 = .9164 ( Figure 4D ). MMP-9 relat ive density showed 34% inhibition at 100 µg/mL, 95% at 500 µg/mL, and 100% at 1000 µg/mL NM, with R 2 = .8439 ( Figure 4D ).
Matrigel invasion. NM significantly inhibited FaDu invasion through Matrigel in a dose-dependent manner, with 74% (P = .003) inhibition at 50 µg/mL, 85% (P = .002) at 100 µg/mL, and 100% (P = .001) at 500 µg/mL, as shown in Figure 5 . There was significant negative correlation between NM concentration and number of FaDu cells that invaded/migrated through Matrigel: r = −.5410, P = .0204.
Morphology (H&E staining) and apoptosis (live green caspases detection kit).
H&E staining showed no morphological changes at 100 µg/mL NM, but apoptotic cells were evident at 500 and 1000 µg/mL, as shown in Figure 6A -F. The apoptotic cells showed shrinkage with condensed and darkly stained nuclei and strongly acidophilic cytoplasm. Using the live green caspase kit, dose-dependent apoptosis of FaDu cells was evident with NM challenge, as shown in Figure 7A -F. Approximately 50% of cells exposed to 100 µg/mL NM were apoptotic; the number of apoptotic cells increased significantly in a dose-dependent manner at 250 to 1000 µg/mL NM. Quantitative analysis of live, early, and late apoptotic cells is shown in Figure 8 . At 100 µg/ mL NM, 44.7% of cells are viable, 13.2% in early apoptosis, and 42.1% in late apoptosis, and at 250 µg/mL NM, 24.1% of cells are viable, 12.1% in early apoptosis, and 63.8% in late apoptosis. FaDu cell apoptosis was further increased in cells exposed to 500 µg/mL NM: 11.5% viable, 11.1% early apoptosis, and 77.4% late apoptosis. Virtually all cells exposed to 1000 µg/mL NM were in late apoptosis: 4.8% viable, 2.9% in early apoptosis, and 92.4% in late apoptosis.
Discussion
The results of the in vivo study of human FaDu xenografts in immune impaired (athymic) male nude mice demonstrated significant suppression of FaDu tumor growth (55% reduction in tumor weight) with NM dietary supplementation. Results from the cellular proliferation and apoptosis studies support the in vivo findings, as NM showed dose-dependent toxicity in FaDu cells and induced apoptosis in FaDu cells in a dose-dependent manner, with 53% inhibition of cell growth and apoptotic induction of virtually all cells exposed to 1000 µg/mL NM.
Tumor growth depends on the generation of new blood vessels to sustain cellular survival and proliferation. A, Control; B, NM 10 µg/mL; C, NM 50 µg/mL; D, NM 100 µg/mL; E, NM 500 µg/mL; F, NM 1000 µg/mL.
Growing tumors become hypoxic and acidotic beyond the size of 2 mm and secrete several growth factors to stimulate local blood vessels to sprout branches. Activation of endothelial cells leads to production of MMPs, enabling degradation of the surrounding ECM and eventual development of new blood vessels. In a previous study, NM significantly (P < .05) reduced bFGF-induced angiogenesis (using a chorioallantoic membrane assay in chick embryos), as well as decreased human osteosarcoma U2OS cell expression of VEGF, angiopoietin-2, bFGF, PDGF, and TGFbeta-1. A -Control, B -NM 50 µg/ml, C -NM 100 µg/ml, D -NM 250 µg/ml, E -NM 500 µg/ml, F -1000 µg/ml Invasion of host tissues depends on tumor cell adhesion, cell migration, and proteolytic degradation of the ECM by MMPs. 26 As mentioned previously, MMPs, especially MMP-2 and MMP-9, are prognostic for survival and metastatic potential in head and neck cancers. In examination of MMP plasma and tissue levels in oral cancer patients, Patel et al 27 found that latent, active, and total forms of MMP-2 and MMP-9 were significantly elevated in malignant tissue compared with adjacent normal tissues and that MMP-2 was correlated with lymph node metastatic development. In examination of gelatinolytic activity in human oral squamous cell carcinoma tissues, Kawamata et al 8 demonstrated increased activity of pro-MMP-9 and active MMP-2 in cancer cell nests compared with normal surrounding gingival tissue and significantly higher MMP-2 activity in metastatic cancer cell nests. In examining a group of patients with early stage oral squamous cell carcinoma, Katayama et al 28 found that patients who developed regional lymph node and/or distant metastasis showed significantly increased MMP-9 and TIMP-2 expression than patients without any tumor metastasis. In addition, expression of MMP-9 and TIMP-2 correlated with worse-cause-specific survival. Reidel et al 29 found that MMP-9 expression in patients with HNSCC correlated with poor survival of patients, high VEGF expression, and higher mean vessel density than MMP-9-negative tumors. These findings indicate that MMP-9 functions as a regulator of tumor angiogenesis supporting endothelial cell invasion in human head and neck cancer. Kuhara et al 30 demonstrated a significant decrease in ECM staining (indicating loss of ECM) in cases of oral squamous cell carcinoma with increased expression of MMP-1, MMP-2, and MMP-9. Increased expression of MMP-1, MMP-2, MMP-3, MMP-9, and MT1-MMP was observed both in invasive and metastatic cases. The results from our in vitro study of HNSCC demonstrated potent, significant suppression of MMP secretion and Matrigel invasion and migration of FaDu cells at 500 µg/mL.
The relative stability of ECM plays a key role in the development of cancer. We have previously shown that the ECM synthesized by normal fibroblasts treated with NM demonstrated increased stability and significantly reduced osteosarcoma cell growth rate, invasive activity (MMP-2 and MMP-9 secretion and Matrigel invasion), and adhesion to collagen I and other substrates, suppressing tumor growth independent of the immune system function and inhibiting critical steps in cancer metastasis. 13 
Conclusions
The results of the present study show that supplementation with NM was effective in inhibiting growth of FaDu xenografts in nude mice and in inhibiting growth, MMP secretion, Matrigel invasion, and induction of apoptosis in FaDu cell culture. Furthermore, in contrast to the toxic side effects of current chemotherapy, the nutrient mixture has been shown to be a safe therapeutic agent. In a previous in vivo study addressing safety issues, we found that gavaging adult female ODS rats (weighing 250-300 g) with the nutrient mixture (at 30, 90, or 150 mg per day for 7 days) had adverse effects neither on vital organs (heart, liver, and kidney) nor on the associated functional serum enzymes, indicating that this mixture is safe to use even at these high doses, which far exceed the normal equivalent dosage of the nutrient. 31 
